Patients Coming Off Weight-Loss Jabs Gain Back Weight at a Quadrupled Rate Compared to Those on Conventional Diets

Fresh analysis indicates that patients who stop using new slimming jabs like semaglutide or tirzepatide can put back on lost weight much more quickly than those who stop conventional diet and exercise plans.

Published data in a major health publication shows that while obese people can lose about a fifth of their body weight while on the medication, the mass is regained at an average rate of nearly a kilo each month upon discontinuation.

"Users purchasing such medications should be aware of the danger of rapid weight regain when the therapy concludes," cautioned researcher Dr. Susan Jebb.

This pace of regain implies a reversion to pre-treatment mass within about 18 months.

Weighing Approaches

The research, which examined 37 of trials involving over 9,000 of participants, contrasted the effects of these new drugs with other pills.

Researchers emphasize that people who shed pounds through diet and exercise usually have a less rapid creep back—approximately 0.1 kg a month—post-intervention.

Explaining the Rapid Rebound

Doctors believe the mechanism of the injections accounts for the amplified weight return.

The injections copy a body's own chemical called glucagon-like peptide-1, which controls hunger.

"Artificially providing GLP-1 levels far above than the body's typical production may cause the system to generate a reduced amount of its endogenous hormone, and may also lessen responsiveness to its effects," said Dr. Adam Collins, a dietetics researcher.

"Discontinuation of this GLP-1 'fix' means hunger is no longer kept in check, making binge eating a significant risk."

A Lifelong Condition?

Health authorities recommend the injections for people with weight-linked medical conditions, alongside recommended lifestyle changes.

Professionals contend that, considering the significant potential of weight regain, the treatment might need to be life-long.

This opinion is supported by pharmaceutical companies, who state that the results "emphasize the persistent character of obesity," comparing it to managing conditions like diabetes.

User Experiences

Users who have come off the jabs explain a sudden resurgence of appetite.

"It felt as if a trigger activating and you become extremely hungry," recalled an individual.

The struggle is compounded if patients have not developed permanent lifestyle or habit changes during treatment.

Significant Use

Figures show that a significant number of adults in the UK have tried these injections in the last 12 months, with interest continuing to grow.

• Adoption is greater among females compared to males.
• The 40s and 50s demographic shows the highest level of interest.
• A large proportion access the medications through private healthcare rather than the NHS.

In conclusion, researchers emphasize that while GLP-1 drugs are effective tools for shedding pounds, they are not a magic cure and maintained weight loss likely depends on ongoing lifestyle management.